COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.
Stay current on PCCA news and events, market trends, and all things compounding!
We’re reviewing the distinctions between SuspendIt and SuspendIt Anhydrous, as well as how revisions to USP Chapter 795 will guide beyond use dates (BUDs) for aqueous and nonaqueous oral dosage forms.
Access scientific studies, which include images and videos, conducted by PCCA researchers that evaluated properties and performance of SuspendIt Anhydrous.
PCCA Manager of Science Maria Carvalho discusses presenting 40 Stability Stuies on SuspendIt at International Scientific Conferences.
We introduced our patent-pending base during International Seminar 2022. Read how compounding pharmacies, prescribers and patients may benefit from our latest innovation.
Every month, there are new scientific publications involving PCCA products or services. These publications include journal articles, conference abstracts, conference posters, technical reports and case studies. Maria Carvalho , PharmD, MRPharmS, PhD, is the Manager of PCCA Science, she dives into some of the exciting updates for compounders.